-transparent.png){kind=logo}
Twenty-seven patients with skin and soft tissue infections, including three with contiguous osteomyelitis, were given cefoxitin intravenously or intramuscularly; the infections of 25 (93%) were resolved with cefoxitin therapy. Etiologic agents included staphylococci, streptococci, Enterobacteriaceae, and anaerobes. Susceptible pathogens were inhibited by less than or equal to 8 micrograms of cefoxitin/ml. This level of drug was surpassed by mean peak serum concentrations eight- to 12-fold after intravenous infusions and two- to threefold after intramuscular injections and resulted in eradication of susceptible organisms from lesions during treatment. Intravenously administered cefoxitin was well tolerated, although eosinophilia, phlebitis, elevation of levels of hepatic enzymes, and a positive direct Coombs' test were observed. Intramuscular injections of cefoxitin in 0.5% lidocaine caused pain and induration and thus were poorly tolerated.
R L Perkins, and
T G Slama, and
R J Fass, and
R B Prior, and
J F Plouffe, and
J F Warner, and
T M File
July 1978,
The Journal of antimicrobial chemotherapy,
R L Perkins, and
T G Slama, and
R J Fass, and
R B Prior, and
J F Plouffe, and
J F Warner, and
T M File
November 1980,
Delaware medical journal,
R L Perkins, and
T G Slama, and
R J Fass, and
R B Prior, and
J F Plouffe, and
J F Warner, and
T M File
August 1983,
The American journal of medicine,
R L Perkins, and
T G Slama, and
R J Fass, and
R B Prior, and
J F Plouffe, and
J F Warner, and
T M File
July 1978,
The Journal of antimicrobial chemotherapy,
R L Perkins, and
T G Slama, and
R J Fass, and
R B Prior, and
J F Plouffe, and
J F Warner, and
T M File
April 1989,
The Journal of antimicrobial chemotherapy,
R L Perkins, and
T G Slama, and
R J Fass, and
R B Prior, and
J F Plouffe, and
J F Warner, and
T M File
February 2008,
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
R L Perkins, and
T G Slama, and
R J Fass, and
R B Prior, and
J F Plouffe, and
J F Warner, and
T M File
July 1978,
The Journal of antimicrobial chemotherapy,
R L Perkins, and
T G Slama, and
R J Fass, and
R B Prior, and
J F Plouffe, and
J F Warner, and
T M File
December 2006,
Infectious disease clinics of North America,
R L Perkins, and
T G Slama, and
R J Fass, and
R B Prior, and
J F Plouffe, and
J F Warner, and
T M File
May 2000,
The New Zealand medical journal,
R L Perkins, and
T G Slama, and
R J Fass, and
R B Prior, and
J F Plouffe, and
J F Warner, and
T M File
March 2012,
Praxis,
